Published in Clin J Am Soc Nephrol on November 28, 2016
Vancomycin and the Risk of AKI: Now Clearer than Mississippi Mud. Clin J Am Soc Nephrol (2016) 0.75
Vancomycin in the Kidney-A Novel Cast Nephropathy. J Am Soc Nephrol (2017) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med (2002) 17.04
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med (2004) 8.11
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med (2014) 5.05
Single-dose oritavancin in the treatment of acute bacterial skin infections. N Engl J Med (2014) 3.86
Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*. Crit Care Med (2014) 3.45
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother (2008) 3.09
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis (2009) 2.78
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis (2009) 2.54
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther (2007) 2.05
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis (2006) 1.67
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy (2009) 1.55
Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother (2011) 1.54
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther (2003) 1.33
Vancomycin enhancement of experimental tobramycin nephrotoxicity. Antimicrob Agents Chemother (1986) 1.24
Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother (1981) 1.17
Renal tolerance and pharmacokinetics of vancomycin in rats. J Antimicrob Chemother (1984) 1.17
Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res (2003) 1.08
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother (2007) 1.05
Product quality of parenteral vancomycin products in the United States. Antimicrob Agents Chemother (2012) 1.03
Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. Pharmacotherapy (2014) 1.02
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother (2010) 1.02
Linezolid for the treatment of infections caused by Gram-positive pathogens in China. Int J Antimicrob Agents (2008) 1.01
Vancomycin ototoxicity and nephrotoxicity. A review. Med Toxicol Adverse Drug Exp (1989) 1.00
Teicoplanin versus vancomycin for proven or suspected infection. Cochrane Database Syst Rev (2010) 1.00
Vancomycin: an update. Pharmacotherapy (1986) 0.98
Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin. J Infect Dis (1990) 0.94
Studies of risk factors for aminoglycoside nephrotoxicity. Am J Kidney Dis (1986) 0.93
Risk factors for acute kidney injury in adult patients receiving vancomycin. Clin Drug Investig (2014) 0.91
Biopsy-proven acute tubular necrosis in a child attributed to vancomycin intoxication. Pediatr Nephrol (2006) 0.89
Acute interstitial nephritis associated with vancomycin therapy. Arch Intern Med (1988) 0.88
DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin. Allergy Asthma Clin Immunol (2011) 0.88
Tubulointerstitial nephritis due to vancomycin. Am J Kidney Dis (1989) 0.87
Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy (2001) 0.87
Vancomycin-induced acute interstitial nephritis. Ann Pharmacother (1998) 0.86
Vancomycin and nephrotoxicity: just another myth? J Trauma Acute Care Surg (2013) 0.86
Impact of vancomycin or linezolid therapy on development of renal dysfunction and thrombocytopenia in Japanese patients. Chemotherapy (2014) 0.86
Vancomycin-induced acute granulomatous interstitial nephritis: therapeutic options. Am J Med Sci (2007) 0.85
Clinical outcomes of linezolid vs vancomycin in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia: retrospective analysis. J Intensive Care Med (2011) 0.85
Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis. Clin Exp Nephrol (2011) 0.84
High-dose intravenous vancomycin therapy and the risk of nephrotoxicity. Clin Ther (2014) 0.84
Biopsy proven interstitial nephritis following treatment with vancomycin: a case report. Conn Med (2010) 0.80
Teicoplanin nephrotoxicity: first case report. Pharmacotherapy (1992) 0.80
Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity. Int J Nephrol (2011) 0.79
Biopsy-proven acute tubular necrosis associated with vancomycin in an adult patient. Ren Fail (2012) 0.78
Vancomycin and interstitial nephritis. Ann Intern Med (1981) 0.77
Enhancement of tobramycin binding to rat renal brush border membrane by vancomycin. J Pharmacol Exp Ther (1995) 0.77
Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function. Eur J Clin Microbiol Infect Dis (2011) 0.77
Nephrotoxicity of teicoplanin in rats. Jpn J Antibiot (2000) 0.76
Retrospective Analysis of Vancomycin Nephrotoxicity in Elderly Chinese Patients. Pharmacology (2015) 0.76